Session Type
Meeting
Search Results for VTE Prophylaxis
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: A variety of risk prediction scores have been devised to identify patients at increased risk for VTE in different patient populations and settings. Guideline recommendations for VTE risk assessment vary greatly. We performed a systematic review to identify and synthesize evidence on clinical risk prediction scores for VTE in medical and surgical hospitalized patients. […]
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Venous thromboembolism (VTE) is the leading cause of preventable hospital death. National guidelinesrecommend VTE prophylaxis for all medical patients not at low risk. Several VTE risk prediction models have been developed, but no US models have been validated in a medical population. The ACCP recommends use of the Padua risk assessment model with a […]
Oral Presentations
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: A variety of risk prediction scores have been devised to identify patients at increased risk for VTE in different patient populations and settings. Guideline recommendations for VTE risk assessment vary greatly. We performed a systematic review to identify and synthesize evidence on clinical risk prediction scores for VTE in medical and surgical hospitalized patients. […]
Oral Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Venous thromboembolism (VTE) is the leading cause of preventable hospital death. National guidelinesrecommend VTE prophylaxis for all medical patients not at low risk. Several VTE risk prediction models have been developed, but no US models have been validated in a medical population. The ACCP recommends use of the Padua risk assessment model with a […]
Abstract Number: 86
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Clinical practice guidelines state that mobility is supposed to play an important role in determining use and duration of pharmacologic VTE prophylaxis. This study examines whether measured mobility levels relate to pharmacologic VTE prophylaxis use among hospitalized older adults. Methods: Prospective observational data from a sample of community-dwelling older adults aged ≥ 60 years, […]
Abstract Number: 144
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Venous thromboembolism (VTE) is a serious and all too frequent hospital complication, therefore assessing each patient’s individual risk of VTE is an important part of their care. Multiple models are available for risk assessment, however most not only include multiple data points requiring redundant entry, but can be labor intensive and time-consuming to complete on […]
Abstract Number: 181
SHM Converge 2021
Background: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality for hospitalized patients. There are approximately 900,000 new VTE events and 100,000 VTE-related deaths every year. In the United States, more deaths occur due to VTE than breast cancer, AIDS, and motor vehicle accidents combined. VTE are considered preventable events with appropriate prophylaxis; […]
Abstract Number: 204
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Health information technology (HIT) has the potential to decrease rates of hospital-acquired conditions. The Patient Safety Learning Lab (PSLL) developed a suite of HIT tools to engage patients, families, and providers in identifying, assessing, and reducing patient safety threats. The goal of this current evaluation is to quantify the effects of this intervention on […]
Abstract Number: 283
Hospital Medicine 2020, Virtual Competition
Background: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), constitute a major health problem in the United States Health System, with a reported high mortality rate and significant economic toll. Despite the prevalence of VTE and associated mortality, clinicians have struggled in prescribing appropriate VTE prophylaxis for the inpatient population, often […]
Abstract Number: 296
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Despite strong performance on Venous Thromboembolism (VTE) Core Measures, our institutional approach to VTE prophylaxis placed significant burden on providers through frequent automated alerts. Within our Electronic Medical Record (EMR), provider alerts triggered when a patient with at least one identified risk factor for VTE did not have prophylactic medication ordered. However, only 11% […]